Consequences of hypoxia-reoxygenation phenomena in patients with obstructive sleep apnea syndrome

Annals of Saudi Medicine

Volumn 31, Issue 1, 2011, Pages 14-18

  Ciftci, Tansu Ulukavak ^a   Kokturk, Oguz ^a   Demirtas, Senay ^a   Gulbahar, Özlem ^b   Bukan, Neslihan ^b  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; ERYTHROPOIETIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRATE; NITRITE; VASCULOTROPIN;

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HYPOXIA; MAJOR CLINICAL STUDY; MALE; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; REOXYGENATION; SLEEP APNEA SYNDROME;

ADULT; ANOXIA; CONTINUOUS POSITIVE AIRWAY PRESSURE; ENDOTHELIN-1; ERYTHROPOIETIN; FEMALE; FREE RADICALS; HUMANS; MALE; MIDDLE AGED; NITRATES; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; OXYGEN; POLYSOMNOGRAPHY; PROSPECTIVE STUDIES; SLEEP APNEA, OBSTRUCTIVE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79251625184     PISSN: 02564947     EISSN: 09754466     Source Type: Journal    
DOI: 10.4103/0256-4947.75772     Document Type: Article

References (30)

1. Young T, Palta M, Dempsey J Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-5.
2. Ferretti A, Giampiccolo P, Cavalli A, Milic-Emili J, Tantucci C. Expiratory flow limitation and orthopnea in massively obese subjects. Chest 2001;119:1401-8. (Pubitemid 32686021)
3. Newman AB, Foster G, Givelber R, Nieto FJ, Redline S, Young T. Progression and regression of sleep-disordered breathing with changes in weight: The Sleep Heart Health Study. Arch Intern Med 2005;165:2408-13.
4. Partinen M, Guilleminault C. Daytime sleepiness and vascular morbidity at seven year followup in obstructive sleep apnea patients. Chest 1990;97:27-32.
5. Pendlebury ST, Pepin JL, Veale D, Levy P. Natural evolution of moderate sleep apnea syndrome: Significant progression over a mean of 17 months. Thorax 1997;52:872-8.
6. Zaninelli A, Fariello R, Boni E, Corda L, Alicandri C, Grassi V. Snoring and risk of cardiovascular disease. Int J Cardiol 1991;32:347-51.
7. Doherty LS, Kiely JL, Swan V, McNicholas WT. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 2005;127:2076-84.
8. Punjabi NM, Polotsky VY. Disorders of glucose metabolism in sleep apnea. J Appl Physiol 2005;99:1998-2007.
9. Vgontzas AN, Bixler EO, Chrousos G P. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 2005;9:211-24.
10. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques, and scoring system for sleep stages in human subjects. Los Angeles, CA: Brain Information Service, VCLA; 1968.
11. EEG arousals: Scoring rules and examples: A preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992;15:173-84.
12. The report of an American Academy of Sleep Medicine Task Force. Sleep-Related Breathing Disorders in Adults: Recommendations for Syndrome Definition and Measurement Techniques in Clinical Research. Sleep 1999;22:667-89.
13. American Academy of Sleep Medicine (AASM). International Classification of Sleep Disorders. Westchester, United States: AASM; 2005.
14. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999;13:9-22.
15. Aubin P, Le Brun G, Moldovan F, Villette JM, Créminon C, Dumas J, et al. Sandwich-type enzyme immunoassay for big endothelin-I in plasma: Concentrations in healthy human subjects unaffected by sex or posture. Clin Chem 1997;43:64-70.
16. Viinikka L. Nitric oxide as a challenge for the clinical chemistry laboratory. Scand J Clin Lab Invest 1996;56:577-81.
17. Moncada S. The 1991 Ulf von Euler Lecture. The L-arginine: Nitric oxide pathway. Acta Physiol Scand 1992;145:201-27.
18. Loscalzo J, Welch G. Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis 1995;38:87-104.
19. Cohen RA. The role of nitric oxide and other endothelium-derived vasoactive substances in vascular diseases. Prog Cardiovasc Dis 1995;38:105-28.
20. Ip MS, Lam B, Chan LY, Zheng L, Tsang KW, Fung PC, et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J respire Crit Care Med 2000;162:2166-71.
21. Ohike Y, Kozaki K, Iijima K, Eto M, Kojima T, Ohga E, et al. Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure. Circ J 2005;69:221-6.
22. Gozal D, Lipton AJ, Jones KL. Circulating vascular endothelial growth factor leveling patients with obstructive sleep apnea. Sleep 2002;25:59-65.
23. Phillips CL, Yang Q, Williams A, Roth M, Yee BJ, Hedner JA, et al. The effect of short-term withdrawal from continuous positive airway pressure therapy on sympathetic activity and markers of vascular inflammation in subjects with obstructive sleep apnea. J Sleep Res 2007;16:217-25.
24. Gozal D, Lipton AJ, Jones KL. Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea. Sleep 2002;25:59-65.
25. Teramoto S, Kume H, Yamamoto H. Effects of oxygen administration on the circulating vascular endothelial growth factor (VEGF) levels in patients with sleep apnea syndrome. Intern Med 2003;42:681-5.
26. Winnicki M, Shamsuzzaman A, Lanfranchi P, Accurso V, Olson E, Davison D, et al. Erythropoietin and obstructive sleep apnea. Am J Hypertens 2004;17:783-6.
27. Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005;112:2660-7.
28. Chen J, He L, Dinger B, Stensaas LJ. Role of endothelin and endothelin A-type receptor in adaptation of the carotid body to chronic hypoxia. Am J Physiol Lung Cell Mol Physiol 2001;282: L1314-23.
29. Diefenbach K, Kretschmer K, Bauer S, Malzahn U, Penzel T, Roots I, et al. Endothelin-1 gene variant Lys198Asn and plasma endothelin level in obstructive sleep apnea. Cardiology 2009;112:62-8.
30. Gjorup PH, Sadauskiene L, Wessels J, Nyvad O, Strunge B, Pedersen EB. Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea. Am J Hypertens 2007;20:44-52.